Mostrando 3 resultados de: 3
Filtros aplicados
Origen
scopus(3)
Androgen receptor axis-targeted agents for non-metastatic castration-resistant prostate cancer impact on overall survival and safety profile
ReviewAbstract: inTrodUCTion: The management of non-metastatic castration-resistant prostate cancer (nmCrpC) has undPalabras claves:Apalutamide, Castration, Darolutamide, Enzalutamide, Network meta-analysis, prostatic neoplasmsAutores:Briganti A., Diego M. Carrión, Egawa S., Esperto F., Fiori C., Grossmann N.C., Katayama S., Kimura T., Laukhtina E., Mori K., Mostafaei H., Motlagh R.S., Papalia R., Ploussard G., Pradere B., Quhal F., Rajwa P., Schuettfort V.M., Shariat S.F.Fuentes:scopusA gender-related dichotomy in bladder cancer
OtherAbstract:Palabras claves:Autores:Cimadamore A., del Giudice F., Di Trapani E., Diego M. Carrión, Krajewski W., Mori K., Moschini M., Tan W.S., Teoh J.Y.C.Fuentes:scopusCurrent application of the enhanced recovery after surgery protocol for patients undergoing radical cystectomy: lessons learned from European excellence centers
ArticleAbstract: Purpose: There is no consensus on which items of Enhanced Recovery After Surgery (ERAS) should and sPalabras claves:Autores:Abufaraj M., Albisinni S., Aziz A., Cimadamore A., Di Trapani E., Diego M. Carrión, D’Andrea D., Flippot R., Gonsette K., Khalifa J., Krajewski W., Laukhtina E., Mari A., Mori K., Moschini M., Pradere B., Soria F., Tan W.S., Teoh J.Y.C.Fuentes:scopus